Biological Aging Measures Based on Blood DNA Methylation and Risk of Cancer: A Prospective Study
Open Access
- 16 November 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Cancer Spectrum
- Vol. 5 (1) , pkaa109
Abstract
We previously investigated the association between 5 “first-generation” measures of epigenetic aging and cancer risk in the Melbourne Collaborative Cohort Study. This study assessed cancer risk associations for 3 recently developed methylation-based biomarkers of aging: PhenoAge, GrimAge, and predicted telomere length. We estimated rate ratios (RRs) for the association between these 3 age-adjusted measures and risk of colorectal (N = 813), gastric (N = 165), kidney (N = 139), lung (N = 327), mature B-cell (N = 423), prostate (N = 846), and urothelial (N = 404) cancer using conditional logistic regression models. We also assessed associations by time since blood draw and by cancer subtype, and we investigated potential nonlinearity. We observed relatively strong associations of age-adjusted PhenoAge with risk of colorectal, kidney, lung, mature B-cell, and urothelial cancers (RR per SD was approximately 1.2-1.3). Similar findings were obtained for age-adjusted GrimAge, but the association with lung cancer risk was much larger (RR per SD = 1.82, 95% confidence interval [CI] = 1.44 to 2.30), after adjustment for smoking status, pack-years, starting age, time since quitting, and other cancer risk factors. Most associations appeared linear, larger than for the first-generation measures, and were virtually unchanged after adjustment for a large set of sociodemographic, lifestyle, and anthropometric variables. For cancer overall, the comprehensively adjusted rate ratio per SD was 1.13 (95% CI = 1.07 to 1.19) for PhenoAge and 1.12 (95% CI = 1.05 to 1.20) for GrimAge and appeared larger within 5 years of blood draw (RR = 1.29, 95% CI = 1.15 to 1.44 and 1.19, 95% CI = 1.06 to 1.33, respectively). The methylation-based measures PhenoAge and GrimAge may provide insights into the relationship between biological aging and cancer and be useful to predict cancer risk, particularly for lung cancer.Keywords
All Related Versions
Funding Information
- Australian National Health and Medical Research Council (1164455)
- VicHealth and Cancer Council Victoria
- Australian NHMRC (209057, 251553, 504711)
- Cancer Council Victoria
- NHMRC (1011618, 1026892, 1027505, 1050198, 1043616, 1074383)
- Victorian Cancer Agency Early Career Research Fellow (ECRF19020)
- NHMRC Senior Research Fellow (1061177)
- Monash University, Melbourne, Australia
This publication has 36 references indexed in Scilit:
- Global Measures of Peripheral Blood-Derived DNA Methylation as a Risk Factor in the Development of Mature B-Cell NeoplasmsEpigenomics, 2015
- DNA methylation age of human tissues and cell typesGenome Biology, 2013
- Functional DNA methylation differences between tissues, cell types, and across individuals discovered using the M&M algorithmGenome Research, 2013
- The Hallmarks of AgingCell, 2013
- Short Telomere Length, Cancer Survival, and Cancer Risk in 47102 IndividualsJNCI: Journal of the National Cancer Institute, 2013
- Genome-wide Methylation Profiles Reveal Quantitative Views of Human Aging RatesMolecular Cell, 2013
- Alternative Dietary Indices Both Strongly Predict Risk of Chronic DiseaseThe Journal of Nutrition, 2012
- DNA methylation arrays as surrogate measures of cell mixture distributionBMC Bioinformatics, 2012
- Flexible smoothing with B-splines and penaltiesStatistical Science, 1996
- What Does the Odds Ratio Estimate in a Case-Control Study?International Journal of Epidemiology, 1993